Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure

• Status: Completed
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

A randomised controlled trial assessing the efficacy of single versus repeated dose of vaginal misoprostol for the treatment of early pregnancy failure.

• Phase: Phase 4

Details

• Lead Sponsor: Wolfson Medical Center
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• Women with early pregnancy failure, defined as missed abortion or blighted ovum, seeking medical treatment with misoprostol.

• Age equal or greater than 18 years

• Gestational age less than 12 complete weeks.

Exclusion Criteria:

• Complete, incomplete, inevitable, or septic abortion.

• Hemodynamically unstable patients.

• Misoprostol sensitivity or contraindication.

• Multifetal pregnancies.